Meanwhile, ROS may regulate Smads signaling which contributes to cancer cells' resistance to proliferation inhibition by TGF-β [77] in the early stage of tumorigenesis, contrary to the enhancement of MAPK and NF-κB pathways. The gene discussed is TGFB1; the disease is cancer.